ARCHIVES

Phase III Regorafenib Trial Meets PFS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Congressional Action Imminent On Cancer Ac Renewal, Hew Money Bills; Veto Threatened

September 8, 1978

DO RFAs cut Into R01 Grant Pool? Board Asks

July 2, 1999

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

July 29, 2011

ORI finds Hopkins Coordinator Falsified Information On Grant

May 16, 1997

Eppley Contract Renewed; To Be Recompeted

January 20, 1978

In Brief: Staff, Subcommittee Reports Due At NCAB June Meet; CCIRC to Sponsor Symposium On Epidemiology On Oct.

June 6, 1975